|
|
|
E24CHA001 |
EnoGene |
Human-,-Human-IgG1. |
EUR 276.5 |
|
Description: Human , Human IgG1. |
Human IgG antibody Laboratories manufactures the elecsy sars antiobody reagents distributed by Genprice. The Elecsy Sars Antiobody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Elecsy products are available in stock. Specificity: Elecsy Category: Sars Group: Antiobody
Mouse Monoclonal Antiobody to DDR1 |
|
Antagene |
0.1ml |
EUR 260 |
Mouse Monoclonal Antiobody to FABP4 |
|
Antagene |
0.1ml |
EUR 260 |
Mouse Monoclonal Antiobody to AXL |
|
Antagene |
0.1ml |
EUR 260 |
Mouse Monoclonal Antiobody to HAND1 |
|
Antagene |
0.1ml |
EUR 280 |
Mouse Monoclonal Antiobody to ERBB3 |
|
Antagene |
0.1ml |
EUR 280 |
Mouse Monoclonal Antiobody to ERBB3 |
|
Antagene |
0.1ml |
EUR 280 |
Mouse Monoclonal Antiobody to E7 |
|
Antagene |
0.1ml |
EUR 280 |
Antiobody information
Mouse Monoclonal Antiobody to ERBB3 |
|
MAB-606020254 |
Antagene |
0.1ml |
EUR 280 |
Mouse Monoclonal Antiobody to ERBB3 |
|
MAB-606020255 |
Antagene |
0.1ml |
EUR 280 |
Mouse Monoclonal Antiobody to EP300 |
|
MAB-606020261 |
Antagene |
0.1ml |
EUR 280 |
Mouse Monoclonal Antiobody to NCOR1 |
|
MAB-606020265 |
Antagene |
0.1ml |
EUR 320 |
Mouse Monoclonal Antiobody to EphA8 |
|
MAB-606020266 |
Antagene |
0.1ml |
EUR 280 |
Mouse Monoclonal Antiobody to MAP4K4 |
|
MAB-606020235 |
Antagene |
0.1ml |
EUR 320 |
anti-ORF3a (SARS-CoV-2) |
|
AB0372-100 |
SICGEN |
300 µg |
EUR 352 |
- Purification: Epitope affinity purified
- Immunogen: Affinity purified fusion recombinant protein using the C-terminal of ORF3a (residues 160 to stop) and produced in E. coli.
- Specificity test:In lysates of transfected cells with the plasmid containing
- Show more
|
|
Description: ORF3a encodes a viral accessory and uncharacterised protein with possible role in the viral life cycle. Six functional domains have been identified and have linked to infectivity, virulence, ion channel formation and virus release. |
anti-ORF7a (SARS-CoV-2) |
|
AB0379-100 |
SICGEN |
300 µg |
EUR 352 |
- Purification: Epitope affinity purified
- Immunogen: Affinity purified recombinant fusion protein ORF7a (residues 18 to 95) produced in E. coli.
- Specificity test:In lysates of transfected cells with the plasmid containing the sequence used, detects the
- Show more
|
|
Description: ORF7a is a SARS-CoV accessory protein that is composed of a type I transmembrane protein that localizes primarily to the Golgi apparatus and also be found on the cell surface. This protein has been implicated on several mechanisms such as suppressing both transgene and virus-induced gene silencing by reducing the levels of small interfering RNA (siRNA), attachment and modulation of leukocytes by biding to host ITGAL and playing a role as antagonist of host tetherin (BST2) by disrupting its antiviral effect. |
anti-ORF3a (SARS-CoV-2) |
|
AB0408-100 |
SICGEN |
300 µg |
EUR 352 |
- Purification: Epitope affinity purified
- Immunogen: Affinity purified fusion recombinant protein using the C-terminal of ORF3a (residues 160 to stop) and produced in E. coli.
- Specificity test:In lysates of transfected cells with the plasmid containing
- Show more
|
|
Description: ORF3a encodes a viral accessory and uncharacterised protein with possible role in the viral life cycle. Six functional domains have been identified and have linked to infectivity, virulence, ion channel formation and virus release. |
anti-ORF7a (SARS-CoV-2) |
|
AB0409-100 |
SICGEN |
300 µg |
EUR 352 |
- Purification: Epitope affinity purified
- Immunogen: Affinity purified recombinant fusion protein ORF7a (residues 18 to 95) produced in E. coli.
- Specificity test:In lysates of transfected cells with the plasmid containing the sequence used, detects the
- Show more
|
|
Description: ORF7a is a SARS-CoV accessory protein that is composed of a type I transmembrane protein that localizes primarily to the Golgi apparatus and also be found on the cell surface. This protein has been implicated on several mechanisms such as suppressing both transgene and virus-induced gene silencing by reducing the levels of small interfering RNA (siRNA), attachment and modulation of leukocytes by biding to host ITGAL and playing a role as antagonist of host tetherin (BST2) by disrupting its antiviral effect. |
anti-ORF3a (SARS-CoV-2) |
|
MBS448183-03mg |
MyBiosource |
0.3mg |
EUR 330 |
anti-ORF3a (SARS-CoV-2) |
|
MBS448183-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1440 |
anti-ORF7a (SARS-CoV-2) |
|
MBS448185-03mg |
MyBiosource |
0.3mg |
EUR 330 |
anti-ORF7a (SARS-CoV-2) |
|
MBS448185-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1440 |
anti-ORF3a (SARS-CoV-2) |
|
MBS448206-03mg |
MyBiosource |
0.3mg |
EUR 330 |
anti-ORF3a (SARS-CoV-2) |
|
MBS448206-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1440 |
anti-ORF7a (SARS-CoV-2) |
|
MBS448207-03mg |
MyBiosource |
0.3mg |
EUR 330 |
